Loading stock data…
CCAP
$13.93+0.31 (+2.28%)
Market ClosedLast close May 1
Crescent Capital BDC, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Crescent Capital BDC, Inc. in the Financial Services sector is trading at $13.93. The stock is currently 18% below its 52-week high of $17.02, remaining 4.1% above its 200-day moving average. Technical signals show overbought RSI of 77 and bullish MACD crossover, explaining why CCAP maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Overbought levels (RSI 77) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JPMBACGS
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.93
Potential Upside
30.9%
Whystock Fair Value$18.24
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Crescent Capital BDC, Inc. is as a business development company is a private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$498.35M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
14.49
Beta
Defensive asset. Lower volatility than the S&P 500.
0.60
Div Yield
Strong income play. Yield provides a meaningful total return floor.
1246.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
4.89%
Volume
Today's trading volume
175,096
Recent News
Zacks Industry Outlook Highlights Main Street Capital and Crescent Capital
Main Street Capital stands out as falling rates pressure margins in SBIC finance, but rising loan demand, refinancing activity and regulatory flexibility offer support.
Buy These 2 SBIC & Commercial Finance Stocks Despite Industry Weakness
Declining interest rates are likely to weigh on loan yields, while demand for personalized financing is expected to rise. The Zacks SBIC & Commercial Finance industry players like MAIN and CCAP are worth investing in.
Crescent Capital BDC (CCAP) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Crescent Capital BDC (CCAP), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Crescent Capital BDC (CCAP) Moves to Buy: Rationale Behind the Upgrade
Crescent Capital BDC (CCAP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Down 12% in 4 Weeks, Here's Why Crescent Capital BDC (CCAP) Looks Ripe for a Turnaround
Crescent Capital BDC (CCAP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.